Epistaxis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Epistaxis}} | {{Epistaxis}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
'''Editor in Chief''': [[User:Ludi|Liudvikas Jagminas, M.D., FACEP]] [mailto:LJagminas@mhri.org] Phone: 401-729-2419 | '''Editor in Chief''': [[User:Ludi|Liudvikas Jagminas, M.D., FACEP]] [mailto:LJagminas@mhri.org] Phone: 401-729-2419 |
Revision as of 15:28, 9 April 2013
Epistaxis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Epistaxis risk factors On the Web |
American Roentgen Ray Society Images of Epistaxis risk factors |
Risk calculators and risk factors for Epistaxis risk factors |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor in Chief: Liudvikas Jagminas, M.D., FACEP [1] Phone: 401-729-2419
Overview
- Occasionally, nosebleeds may indicate other disorders such as bleeding disorders or high blood pressure.
- Frequent nosebleeds may also be a sign of hereditary hemorrhagic telangiectasia (also called HHT or Osler-Weber-Rendu syndrome).
- Blood thinners such as Coumadin, Plavix, or aspirin may cause or worsen nosebleeds.